Dean et al. extracted acid and neutral metalloproteinases and their inhibitor TIMP from tibial plateau cartilage in 13 OA patients and 7 controls. Three zones were sampled per plateau: fibrillated center, adjacent margin, and remote region. The study asked whether a quantifiable enzyme-inhibitor imbalance underlies cartilage destruction in osteoarthritis.
Cartilage destruction in OA was once attributed simply to wear and inadequate matrix synthesis. This paper reframed it as a failure of biochemical regulation: not just too much enzyme, but a TIMP response that cannot keep pace.
The practical implication is that TIMP quantity alone is misleading. In zone C tissue that looks grossly normal, enzyme levels are already elevated without any compensatory TIMP rise — meaning the whole joint surface is biochemically compromised before fibrillation is visible. This is why OA should not be managed as a focal lesion problem.
When interpreting OA research or designing cartilage-preserving interventions, the medial compartment reflects advanced, potentially obscured disease. The lateral compartment, with milder histology and lower enzyme elevation, offers a cleaner window into early disease mechanisms.
This paper is foundational to understanding why MMP inhibition became a therapeutic target in OA. And why TIMP-based strategies must overcome the fact that even a partial enzyme excess, sustained over time, is sufficient to drive progressive matrix loss.
Dean et al. extracted acid and neutral metalloproteinases and their inhibitor TIMP from tibial plateau cartilage in 13 OA patients and 7 controls. Three zones were sampled per plateau: fibrillated center, adjacent margin, and remote region. The study asked whether a quantifiable enzyme-inhibitor imbalance underlies cartilage destruction in osteoarthritis.
Cartilage destruction in OA was once attributed simply to wear and inadequate matrix synthesis. This paper reframed it as a failure of biochemical regulation: not just too much enzyme, but a TIMP response that cannot keep pace.
The practical implication is that TIMP quantity alone is misleading. In zone C tissue that looks grossly normal, enzyme levels are already elevated without any compensatory TIMP rise — meaning the whole joint surface is biochemically compromised before fibrillation is visible. This is why OA should not be managed as a focal lesion problem.
When interpreting OA research or designing cartilage-preserving interventions, the medial compartment reflects advanced, potentially obscured disease. The lateral compartment, with milder histology and lower enzyme elevation, offers a cleaner window into early disease mechanisms.
This paper is foundational to understanding why MMP inhibition became a therapeutic target in OA. And why TIMP-based strategies must overcome the fact that even a partial enzyme excess, sustained over time, is sufficient to drive progressive matrix loss.